Jean-Olivier Racine is CTO at Outset Medical, Inc. (OM). They have made 12 open-market trades across 1 company since 2022, most recently 2024-05-10.
CIK 0001868039
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OM | 265,325 | $1.2M |
Shares reported on the most recent Form 4, priced at the 2024-05-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OM | SELL | 2024-05-10 | 2024-05-10 | $3.27 | $27K | +26.0% | +32.9% | -65.5% |
| OM | SELL | 2024-02-15 | 2024-02-16 | $3.57 | $7K | -6.3% | -40.5% | +4.8% |
| OM | SELL | 2024-01-16 | 2024-01-17 | $4.29 | $3K | -6.6% | -10.0% | -45.1% |
| OM | SELL | 2024-01-08 | 2024-01-08 | $5.49 | $21K | -31.3% | -39.7% | -51.8% |
| OM | SELL | 2023-11-16 | 2023-11-17 | $4.76 | $4K | +0.4% | +15.1% | -32.0% |
| OM | SELL | 2023-08-16 | 2023-08-17 | $15.10 | $11K | +3.4% | -10.6% | -62.3% |
| OM | SELL | 2023-05-16 | 2023-05-16 | $19.91 | $15K | +6.6% | +14.4% | -19.8% |
| OM | SELL | 2023-02-16 | 2023-02-16 | $24.36 | $18K | -7.4% | -11.4% | -17.6% |
| OM | SELL | 2023-01-27 | 2023-01-30 | $27.92 | $115K | +2.6% | -19.1% | -31.7% |
| OM | SELL | 2022-11-16 | 2022-11-17 | $19.29 | $6K | +10.4% | +29.3% | +31.5% |
| OM | SELL | 2022-08-16 | 2022-08-16 | $21.48 | $6K | -11.1% | -11.9% | -13.6% |
| OM | SELL | 2022-06-23 | 2022-06-24 | $14.50 | $17K | +2.5% | +3.4% | -9.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.